SHIJU VARGHESE JOYCE & Anor v KIDNEY THERAPEUTICS CENTRE PTE. LTD. & Anor

Facts

Mr Shiju Varghese Joyce and his wife Ms Leena Mathew, both nurses, set up Kidney Therapeutics Centre Pte Ltd (KTC), a dialysis business incorporated on 4 May 2021, with Dr Yang Wen-Shin, a nephrologist. Dr Yang held 67% of the shares and Ms Leena 33%; Mr Shiju was not a registered shareholder because he then worked for another dialysis provider. He later worked for KTC as a nurse and was briefly its company secretary.

The claimants said that at a meeting on 2 May 2021 the three made an oral founding agreement for equal profit-sharing, management by the claimants, no fees for Dr Yang, and unanimous decisions. Dr Yang denied it, saying that only certain terms, including profit-sharing by shareholding, were agreed with Mr Shiju on 27 April 2021. After the 2022 accounts showed a profit, Dr Yang took a backdated Medical Director Fee of $40,600. At the first AGM on 27 August 2022 Ms Leena was not re-appointed as a director, and Dr Yang's wife became managing director. Mr Shiju's employment was terminated on 2 February 2023, and in April 2023 a competing dialysis centre, of which he was a director and shareholder, was incorporated next door. The claimants sued in HC/OC 235/2024 for breach of the alleged agreement, misrepresentation and minority oppression under s 216 of the Companies Act 1967.

Issues

1. Whether the claimants and Dr Yang entered into the alleged oral founding agreement
2. Whether Dr Yang misrepresented that he would honour the founding agreement
3. Whether Dr Yang conducted KTC's affairs in a commercially unfair manner amounting to oppression under s 216

Holding

The High Court dismissed the claim in its entirety, finding that the claimants had not proved breach of the founding agreement, misrepresentation or minority oppression on a balance of probabilities. The parties were directed to file submissions on costs.

Reasoning

The claimants bore the burden of proving the agreement existed, not merely its terms. They had no contemporaneous documents and relied on later conduct, which the court found ambiguous and rarely enough on its own. The conduct relied on did not fit: Mr Shiju became secretary only a year later, the word "retired" tracked KTC's constitution, and a director's appointment says nothing about unanimity. Mr Shiju's own message saying Dr Yang had been ready to share 40% of profits contradicted an equal split. Tellingly, the claimants' former solicitors' letters never mentioned the agreement. The misrepresentation claim, built entirely on the agreement, fell with it.

On oppression, the court held that Ms Leena held at least part of her shares for Mr Shiju, so his economic interests could be considered through her claim. It also found that the parties shared a personal relationship of some mutual trust, so informal understandings could in principle form part of the commercial agreement, although the pleaded expectations all rested on the founding agreement. Even so, no unfairness was shown. The Medical Director Fee was drawn only once KTC was profitable, consistent with both sides' accounts, and a separate $28,000 directors' fee complaint had not been pleaded. Any expectation that Ms Leena would remain a director was not absolute; Mr Shiju's plans for a competing centre gave just cause and raised concerns about clean hands. Mr Shiju's dismissal followed his contract. Shareholders have no general right to financial information outside s 203, and Dr Yang eventually supplied the documents. Dr Yang's and his wife's salaries were justified by their workload. No dividend was possible for the year KTC made a loss of $341,378, and for the profitable earlier year the AGM failed for want of a quorum when Ms Leena did not attend, and she took no step to seek a dividend.

From the judgment